Medical Developments International | MVP - Umsatzerlöse

Aktienkurs
0.46
Täglich Wechseln
0.02 4.55%
Monatlich
24.32%
Jährlich
-23.33%
Q2 Prognose
0.51




Der Umsatz Veränderung Datum
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Clinuvel Pharmaceuticals AUD 36.93M 22.44M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Genetic Signatures AUD 11.19M 5.56M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organon & Co USD 1.51B 90M 2025-12
Paradigm Biopharmaceuticals AUD 284.06K 292.06K 2025-12
PYC Therapeutics AUD 11.04M 2.44M 2025-12
Starpharma Holdings AUD 10.83M 9.12M 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12
Viatris USD 3.7B 60M 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12